"Há mais de 80 anos o Hospital Bruno Born é referência em saúde nas mais diversas especialidades, seja de alta ou média complexidade. É uma instituição filantrópica, de direito privado, está inscrita nos Conselhos Nacional, Estadual e Municipal de Assistência Social, e é reconhecida como Utilidade Pública Federal, Estadual e Municipal. Ao promover a saúde oferecendo um atendimento que se estende durante todo o ciclo de vida de seus pacientes, o hospital reafirma suas diretrizes voltadas ao constante aprimoramento de seus recursos físicos, técnicos e humanos. É assim que se constrói uma instituição do mais alto nível, preparada para enfrentar os desafios com muita competência e profissionalismo."

During the past decade, Hospital Bruno Born conducted 21 clinical trials. In the 10-year time frame, 21 clinical trials started and 15 clinical trials were completed, i.e. on average, 71.4% percent of trials that started reached the finish line to date. In the past 5 years, 6 clinical trials started and 12 clinical trials were completed. i.e. 200% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Hospital Bruno Born" #1 sponsor was "EMD Serono Research & Development Institute, Inc." with 3 trials, followed by "R-Pharm International, LLC" with 3 trials sponsored, "Boehringer Ingelheim" with 2 trials sponsored, "Eli Lilly and Company" with 2 trials sponsored and "Hoffmann-La Roche" with 2 trials sponsored. Other sponsors include 5 different institutions and companies that sponsored additional 13 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Hospital Bruno Born" #1 collaborator was "Merck KGaA, Darmstadt, Germany" with 3 trials as a collaborator, "OCT Clinical Trials" with 3 trials as a collaborator, "Bristol-Myers Squibb" with 2 trials as a collaborator, "Quintiles, Inc." with 2 trials as a collaborator and "Brazilian Research In Intensive Care Network" with 1 trials as a collaborator. Other collaborators include 4 different institutions and companies that were collaborators in the rest 14 trials.

According to Clinical.Site data, the most researched conditions in "Hospital Bruno Born" are "Rheumatoid Arthritis" (3 trials), "Carcinoma, Non-Small-Cell Lung" (2 trials), "Metastatic Breast Cancer" (2 trials), "Brain Death" (1 trials) and "Breast Cancer" (1 trials). Many other conditions were trialed in "Hospital Bruno Born" in a lesser frequency.

Most popular intervention types in "Hospital Bruno Born" are "Drug" (21 trials), "Other" (4 trials) and "Biological" (2 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (6 trials), "Paclitaxel" (5 trials), "Carboplatin" (4 trials), "Avelumab" (3 trials) and "Abemaciclib" (2 trials). Other intervention names were less common.

The vast majority of trials in "Hospital Bruno Born" are 21 trials for "All" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "Hospital Bruno Born". undefined are not yet recruiting, 1 are recruiting, 3 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 16 completed trials in Hospital Bruno Born, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Hospital Bruno Born, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 19 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 1 trials that are defined as “Not Applicable".